Development Level

Tbio 4 | 11,651
Tclin 3 | 612
Tchem 2 | 1,388

Collection

GPCR: IDG Consortium (Complete... 1 | 25
GPCR: IDG Consortium (Targets) 1 | 126
RFA-RM-18-021 1 | 328

IMPC Phenotype

decreased CD4-positive, alpha ... 1 | 7
decreased CD8-positive, alpha-... 1 | 8
decreased T cell number 1 | 15
decreased bone mineral density 1 | 126
female infertility 1 | 60
increased IgG2b level 1 | 1
increased mean corpuscular vol... 1 | 92

Disease

Carcinoma 7 | 11,493
Bipolar Disorder 5 | 666
Depressive disorder 5 | 409
Schizophrenia 5 | 1,160
medulloblastoma, large-cell 5 | 6,241
Migraine 4 | 83
Parkinson's disease 4 | 392
ependymoma 4 | 4,679
glioblastoma 4 | 5,792
primitive neuroectodermal tumor 4 | 3,035
Astrocytoma, Pilocytic 3 | 3,081
Hyperactive behavior 3 | 91
Hyperkinesis 3 | 32
Hypotension 3 | 82
Mental Depression 3 | 333
Mood Disorders 3 | 184
adult high grade glioma 3 | 3,801
atypical teratoid / rhabdoid tumor 3 | 5,112
group 3 medulloblastoma 3 | 4,104
intraductal papillary-mucinous adenoma (IPMA) 3 | 2,955
lung adenocarcinoma 3 | 2,716
lung carcinoma 3 | 2,843
non-small cell lung cancer 3 | 2,890
oligodendroglioma 3 | 2,850
osteosarcoma 3 | 7,950
ovarian cancer 3 | 8,520
psoriasis 3 | 6,694
Acromegaly 2 | 51
Alcohol dependence 2 | 107
Alcoholic Intoxication, Chronic 2 | 289
Allergic rhinitis 2 | 95
Amphetamine-Related Disorders 2 | 74
Anxiety Disorders 2 | 38
Asthma 2 | 385
Atopic dermatitis 2 | 952
Attention deficit hyperactivity disorder 2 | 278
Autistic Disorder 2 | 364
Breast cancer 2 | 3,578
Cancer 2 | 2,499
Cardiomyopathies 2 | 110
Cocaine-Related Disorders 2 | 92
Huntington's disease 2 | 76
Hyperalgesia 2 | 83
Hyperprolactinemia 2 | 27
Irritable bowel syndrome 2 | 60
Kidney cancer 2 | 2,613
Major Depressive Disorder 2 | 301
Movement Disorders 2 | 55
Pain 2 | 103
Panic disorder 2 | 61
Psychotic Disorders 2 | 151
Seizures 2 | 596
Substance abuse 2 | 59
Unipolar Depression 2 | 250
Vascular disease 2 | 319
astrocytic glioma 2 | 2,597
colon cancer 2 | 1,478
ductal carcinoma in situ 2 | 1,745
gastric carcinoma 2 | 807
intraductal papillary-mucinous carcinoma (IPMC) 2 | 2,989
intraductal papillary-mucinous neoplasm (IPMN) 2 | 3,291
lung cancer 2 | 4,740
pancreatic ductal adenocarcinoma liver metastasis 2 | 1,962
pituitary cancer 2 | 1,972
post-traumatic stress disorder 2 | 40
Abnormalities, Multiple 1 | 13
Acute Lung Injury 1 | 22
Amenorrhea 1 | 58
Anorexia 1 | 43
Apraxia 1 | 26
Attention Deficit Disorder with Hyperactivity 1 | 21
Catalepsy 1 | 15
Cholera 1 | 34
Cluster headache syndrome 1 | 8
Conduct disorder 1 | 33
Depressed mood 1 | 17
Drug allergy 1 | 36
Edema 1 | 81
Entropion 1 | 22
Erectile dysfunction 1 | 32
Flushing 1 | 60
Food allergy 1 | 8
Generalized anxiety disorder 1 | 29
Gilles de la Tourette syndrome 1 | 47
Heroin dependence 1 | 30
Hypokalemia 1 | 52
Idiopathic scoliosis 1 | 31
Koolen de Vries syndrome 1 | 18
Nasal congestion 1 | 23
Nonorganic psychosis 1 | 84
Postencephalitic parkinsonism 1 | 12
Psychoses, Substance-Induced 1 | 17
Pulmonary emphysema 1 | 48
Rhinitis 1 | 55
Sepsis 1 | 24
Substance Withdrawal Syndrome 1 | 55
Sudden infant death syndrome 1 | 32
Torticollis 1 | 18
Vascular headache 1 | 7
chronic kidney disease 1 | 90

Tissue

Digestive Tract 9 | 17,369
Endocrine System 9 | 18,159
Female tissues 9 | 17,400
Male tissues 9 | 17,142
Nervous System 9 | 16,725
Respiratory system 8 | 16,393
Skin and soft tissues 8 | 17,230
Urinary Tract 8 | 16,678
Blood and immune system 7 | 16,909
Liver and Pancreas 7 | 16,750
Cardiovascular System 6 | 15,192

Target Family

GPCR 7 | 408
Enzyme 1 | 4,145
Non-IDG 1 | 12,091

GO Process

positive regulation of adenyla... 9 | 9
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
VIP peptides VIP Tbio Non-IDG -3.55718 4092.5 322
D(1B) dopamine receptor DRD5 Tchem GPCR -2.33008 183.7 304
D(1A) dopamine receptor DRD1 Tclin GPCR -2.55049 294.2 485
Adhesion G-protein coupled receptor G6 ADGRG6 Tbio GPCR -1.77056 55.1 110
G-protein coupled estrogen receptor 1 GPER1 Tchem GPCR -2.78141 706.4 288
Adenosine receptor A2a ADORA2A Tclin GPCR -2.98333 954.1 244
Corticotropin-releasing factor receptor 1 CRHR1 Tclin GPCR -2.89003 726.5 369
Pituitary adenylate cyclase-activating polypeptide ADCYAP1 Tbio Enzyme -3.05115 1255.2 174
Adhesion G-protein coupled receptor D1 ADGRD1 Tbio GPCR -0.95163 9.75 120